tradingkey.logo

ENDRA Life Sciences Inc

NDRA
View Detailed Chart

3.780USD

+0.694+22.52%
Close 04/23, 16:00ETQuotes delayed by 15 min
2.03MMarket Cap
LossP/E TTM

ENDRA Life Sciences Inc

3.780

+0.694+22.52%
Intraday
1m
30m
1h
D
W
M
D

Today

+22.52%

5 Days

+19.62%

1 Month

-12.09%

6 Months

-74.17%

Year to Date

-39.62%

1 Year

-99.14%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 1 analysts
BUY
Current Rating
75.000
Target Price
2330.88%
Rising Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

556
Total
5
Median
6
Average
Company name
Ratings
Analysts
ENDRA Life Sciences Inc
NDRA
1
CRISPR Therapeutics AG
CRSP
29
Intellia Therapeutics Inc
NTLA
28
Regeneron Pharmaceuticals Inc
REGN
28
Moderna Inc
MRNA
27
Exact Sciences Corp
EXAS
27
1
2
3
...
111

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

1m
15m
30m
1h
D
W
M
1m
15m
30m
D
Sell
Sell(7)
Neutral(3)
Buy(3)
Indicators
Sell(3)
Neutral(3)
Buy(1)
Indicators
Value
Direction
MACD(12,26,9)
-0.061
Sell
RSI(14)
49.343
Neutral
STOCH(KDJ)(9,3,3)
20.147
Neutral
ATR(14)
0.956
High Vlolatility
CCI(14)
-10.828
Neutral
Williams %R
74.528
Sell
TRIX(12,20)
-0.719
Sell
StochRSI(14)
100.000
Buy
Moving Average
Sell(4)
Neutral(0)
Buy(2)
Indicators
Value
Direction
MA5
3.449
Buy
MA10
3.622
Buy
MA20
3.833
Sell
MA50
4.084
Sell
MA100
4.773
Sell
MA200
25.494
Sell

News

More news coming soon, stay tuned...

Company

ENDRA Life Sciences Inc. is developing an enhanced ultrasound technology platform - Thermo Acoustic Enhanced Ultrasound (TAEUS), a technology which characterizes tissue similar to a magnetic resonance imaging (MRI). The Company's TAEUS technology uses radio frequency (RF) pulses to stimulate tissues, using a small fraction (less than 1%) of the amount of energy that would be transmitted into the body during an MRI scan. The use of RF energy allows its TAEUS technology to penetrate deep into tissue, enabling the imaging of human anatomy at depths equivalent to those of conventional ultrasound. The RF pulses are absorbed by tissue and converted into ultrasound signals. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor steatotic liver disease (SLD), a chronic liver disease spectrum. It is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.
Company codeNDRA
CompanyENDRA Life Sciences Inc
CEOMr. Alexander Y. Tokman
Websitehttps://www.endrainc.com/